28.03.2011 • News

3i Kicks Off Azelis Chemicals Sale

British private equity firm 3i Group has kicked off the sale of Azelis, a Belgium headquartered chemicals distributor with €1 billion euros in sales, people familiar with the situation said.

London-listed 3i has hired Bank of America Merrill Lynch to sell the company, which it acquired in 2007 in a €315 million deal, two people said.

The firm hopes to run a tightly controlled auction process, focusing on potential trade buyers, one of those people said. 3i declined to comment.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

most read